Christopher Hutchison, MD
Obstetrics & Gynecology · Riverton, UTNPI 1134151384
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $59,673 of the $73,960 with a category attached, or 80.7%. AbbVie accounts for 80.8% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2019 at $40,976 and has fallen 95.5% since, to $1,851 in 2025. Among obstetrics & gynecology clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 234 payments — averaging $316.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$60K
- Intuitive Surgical$6K
- Organon$5K
- Merck$2K
- Biogen$149
- Exeltis, USA Inc.$136
- plus $833 from 18 others
What the payments were for
- Speaking & faculty fees$59,67381%
- Travel & lodging$7,51810%
- Food & beverage$2,7624%
- Education$4,0075%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 139 | $59,771 |
| Intuitive Surgical | 15 | $6,464 |
| Organon | 16 | $4,544 |
| Merck | 7 | $2,062 |
| Biogen | 7 | $149 |
| Exeltis, USA Inc. | 8 | $136 |
| Medtronic | 2 | $134 |
| Pfizer | 7 | $128 |
| Hologic Sales And Service, LLC | 7 | $115 |
| Bayer | 7 | $96 |
| Evofem Biosciences, Inc. | 3 | $59 |
| Coopersurgical, Inc. | 2 | $51 |
| Axonics, Inc. | 2 | $48 |
| Sumitomo Pharma America, Inc. | 2 | $29 |
| Myovant Sciences Inc. | 1 | $26 |
| Hologic Inc | 1 | $24 |
| Johnson & Johnson | 1 | $24 |
| Therapeuticsmd, Inc. | 1 | $20 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $18 |
| Gilead | 1 | $16 |
| Roche Diagnostics Corporation | 1 | $14 |
| Tris Pharma Inc | 1 | $14 |
| Shield Therapeutics Inc | 1 | $13 |
| Mayne Pharma Commercial LLC | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Orilissa$53,589
- ORIAHNN$11,625
- NEXPLANON$6,271
- DAVINCI XI$4,000
- Da Vinci Surgical System$2,331
How this compares
$73,960 in reported general payments places this provider in the 95th percentile of 294 obstetrics & gynecology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 52 | $993 |
| Norethindrone | 14 | $420 |
| Ibuprofen | 13 | $101 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Riverton
- Janet EddyRiverton$14K
- Adam WrayRiverton$8K
- Chadwick DensleyRiverton$7K
- Kristen BlackRiverton$5K
- David TurokSalt Lake City$968K
- Scott JacobProvo$128K
- Mark StowersBountiful$121K
- Jeffrey RogersSt George$36K
- Stephanie HendersonSandy$32K
- Kevin JensenWest Jordan$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.